In this online CME self-learning program: The overall learning activity will focus on Anticoagulant and Antithrombotic therapy, and the role of the physicians and allied health professions play in it. Anticoagulant therapy remains a common source of medication errors. As a current and longstanding National Patient Safety Goal, anticoagulation therapy is recognized as engendering gaps in practice.
Agenda
➢Statistics and barriers: how anticoagulation proves a persistent patient safety challenge
➢Joint Commission National Patient Safety Goal updates and strategies for implementation and adaptation
➢Clinical challenges
• What happens when we give too much? A rational approach to reversal
• What happens when we give too little? Missed opportunities in the prevention of thromboembolic events
• Special challenges relating to perioperative anticoagulation bridging and neuraxial blockade
• A rational approach to reversal agents and how we learn from them
• Reversal of novel anticoagulants
➢The evolving role of informatics and clinical decision support in anticoagulation
➢Medication formulation and handling challenges
• Heparin’s change in potency
• Dose-splitting of warfarin tablets: why vs. why not?
• Storage of newer oral anticoagulants
➢Putting it all together: best practices, summary, conclusions, and the role of the patient safety coordinator
Healthcare professionals, including physicians, pharmacists, and mid-level practitioners working in acute care hospitals and other healthcare settings.
Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim.
Release Date: December 30, 2013 -- Expiration Date: December 30, 2015
Faculty: John Fanikos, RPh, MBA
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is our policy to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.
Faculty Disclosure: John Fanikos, RPh, MBA reports that he has no relevant financial disclosures.
Disclosures of Educational Planner: Charles Turck, PharmD has no relevant financial disclosures.
Disclosures of Educational Planner: Ambra King, PharmD (ASMSO) has no financial disclosures.
Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.